BX-795

CAT: 0498-bs-82983C-01Size: 5 mgDry Ice: NoHazardous: No
CAT#:0498-bs-82983C-01Size:5 mg
Selected
AVAILABILITY: InStock
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Product image 1
1 / 1
Background
BX795, originally described as a moderately potent inhibitor of PDK1 (IC50 = 111 nM) 1, is, more importantly, a dual inhibitor of TBK1 and IKKε (IC50’s = 6 and 41 nM respectively) 2. TBK1 and IKKε regulate the production of Type I interferons during bacterial and viral infection via phosphorylation of the transcription factor IRF3. It also inhibited of MARK, MLK, NUAK, AurB, and ERK8.3 BX795 exhibited antitumor activity in human oral squamous cell carcinoma4, pancreatic ductal adenocarcinoma5, and Glioblastoma Multiforme6. BX795 has been used to enhance lentiviral transduction efficiency in human NK cells7-9 and human primary T cells10 for CAR-T cell therapy.
Conjugation
Unconjugated
Buffer
Off-white solid
Storage Conditions
-20°C

Related Products

Popular Products